Skip to content
IconOVir
  • About Us
    • Meet our Team
    • Board of Directors
    • Scientific Advisory Board
  • News/Events
    • Press Releases
    • Posters/Publications
  • Careers
  • Contact
Menu
  • About Us
    • Meet our Team
    • Board of Directors
    • Scientific Advisory Board
  • News/Events
    • Press Releases
    • Posters/Publications
  • Careers
  • Contact

Day: November 10, 2022

IconOVir Announces New Preclinical Data Showcasing Best-in-Class Potential of ICVB-1042, its Lead Oncolytic Virus, at SITC 2022

— ICVB-1042 demonstrates selective replication, broad tropism and anti-tumor activity across multiple in vitro and in vivo models — — Proprietary Ad5/Ad34 mutation improves viral entry into target tumor cells, enhancing tropism — — On track to initiate Phase 1 trial in solid tumors in 1H 2023 —  SAN DIEGO, CA., November 10, 2022 – […]

CORPORATE OFFICE

IconOVir Bio
4570 Executive Drive
Suite 350
San Diego, CA 92121

 

Partnering Inquiries
info@iconovir.com
MEDIA INQUIRIES AT
media@iconovir.com
Linkedin
Contact Us
CORPORATE OFFICE

IconOVir Bio
4570 Executive Drive
Suite 350
San Diego, CA 92121

 

Partnering Inquiries
info@iconovir.com
MEDIA INQUIRIES AT
media@iconovir.com
Linkedin
Contact Us
CORPORATE OFFICE

IconOVir Bio
4570 Executive Drive
Suite 350
San Diego, CA 92121

 

Partnering Inquiries
info@iconovir.com
MEDIA INQUIRIES AT
media@iconovir.com
Linkedin
Contact Us
©2022 IconOVir Bio
©2022 IconOVir Bio